A Clinical Trial to Assess the Long Term Safety and Tolerability of MK-0653H in Japanese Participants With Hypercholesterolemia (MK-0653H-833)
PHASE3CompletedINTERVENTIONAL
Enrollment
135
Participants
Timeline
Start Date
May 18, 2016
Primary Completion Date
December 11, 2017
Study Completion Date
December 11, 2017
Conditions
HypercholesterolemiaFamilial Hypercholesterolemia
Interventions
DRUG
Ezetimibe
DRUG
Rosuvastatin
All Listed Sponsors
lead
Organon and Co
INDUSTRY
NCT02748057 - A Clinical Trial to Assess the Long Term Safety and Tolerability of MK-0653H in Japanese Participants With Hypercholesterolemia (MK-0653H-833) | Biotech Hunter | Biotech Hunter